NB-PP_1170x120

NACDS

NACDS grant partners increase visibility on adult vaccination

NACDS grant partners increase visibility on adult vaccination

ARLINGTON, Va. — NACDS grant partners have published articles in the journal Vaccine outlining the results of projects designed to increase adult vaccination. The prevalence of vaccine-preventable diseases in adults remains a significant public health issue in the United States. The demonstration projects were supported both by the Center for Disease Control and Prevention (CDC) and NACDS.

NACDS’ Anderson reflects on President George H.W. Bush

NACDS’ Anderson reflects on President George H.W. Bush

ARLINGTON, Va. — This week, NACDS joined with the nation in looking back on the life and leadership of former President George H.W. Bush. NACDS president and chief executive officer Steven Anderson issued the following reflections: “NACDS has had a wonderful relationship with President Bush and his family for many years. They have always answered

NACDS sends members analysis of 2018 state elections

NACDS sends members analysis of 2018 state elections

ARLINGTON, Va. — The National Association of Chain Drug Store (NACDS) has provided to the membership a state-by-state overview of the 2018 elections, and their implications for a pro-patient, pro-pharmacy policy agenda. The memo described the election results for state legislative chambers and governor’s races. The state-election analysis follows a previously distributed summary of federal-election

NACDS briefs membership on industry-specific election dynamics

NACDS briefs membership on industry-specific election dynamics

In a memo to NACDS chain and associate members today, NACDS president and chief executive officer Steven Anderson, described detailed results of the 2018 Congressional elections from a pharmacy-specific perspective. The memo described changes in the leadership of key healthcare committees, the election results for Congressional champions of specific pharmacy issues, and other insights. The

NACDS touts valuable pharmacist tool for National Diabetes Month

NACDS touts valuable pharmacist tool for National Diabetes Month

ARLINGTON, Va. — NACDS highlighted a newly-released guide from the Centers for Disease Control and Prevention earlier this year in an op-ed in Morning Consult. The guide is even more timely now that it is National Diabetes Month, which brings awareness to a disease that affects nearly 30 million people in the United States—and counting.

Congress views DIR fee impact, pharmacy value on home turf

Congress views DIR fee impact, pharmacy value on home turf

ARLINGTON, Va. — Lawmakers back in their congressional districts while Congress is on recess had an opportunity through the NACDS RxIMPACT grassroots advocacy program to discuss with pharmacists the critical repercussions caused by pharmacy direct and indirect remuneration (DIR) fees. House Ways & Means Committee Member Rep. Erik Paulsen (R, Minn.) and House Energy &

NACDS invited to White House event on October 24

NACDS invited to White House event on October 24

ARLINGTON, Va. — NACDS has been invited back to the White House for an event on Wednesday, October 24, that is titled “A Year of Historic Action to Combat the Opioid Crisis.” We also anticipate soon President Trump’s signing of the SUPPORT for Patients and Communities Act – which reflects aspects of all four of the policy

NACDS board of directors members meet with Congress

NACDS board of directors members meet with Congress

WASHINGTON — Members of the NACDS Board of Directors traveled to Washington, D.C. last week to meet with ten Senators and Representatives with pivotal leadership and committee posts, with Administration officials, and with key Congressional staff. The Board’s meeting agenda mirrored the NACDS “Access Agenda” — which conveys the sense that just as pharmacists provide

House passes NACDS policy recommendations in Opioid Bill

House passes NACDS policy recommendations in Opioid Bill

ARLINGTON, Va. – The opioid-abuse-prevention legislation crafted by U.S. Senate and U.S. House of Representatives negotiators reflects aspects of all four of the policy topics recommended by the National Association of Chain Drug Stores (NACDS). The House passed the bill today, and the Senate anticipates voting next week. The SUPPORT for Patients and Communities Act (H.R. 6) includes the

House sends NACDS-backed “gag clause” bill to President

House sends NACDS-backed “gag clause” bill to President

ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) lauded Congressional leaders for their efforts to empower pharmacists help patients reduce out-of-pocket drug costs. The U.S. House of Representatives approved the Senate-passed versions of the Patient Right to Know Prices Act (S. 2554) and the Know the Lowest Price Act (S. 2553), thus

NACDS is committed in changing times

NACDS is committed in changing times

DENVER — The chain pharmacy industry is going through a period of dramatic transformation, according to Steve Anderson, president and chief executive officer of the National Association of Chain Drug Stores. During the business program at the NACDS Total Store Expo here last month, Anderson highlighted the emerging trade war stemming from President Trump’s tariffs

NACDS applauds California e-prescribing Law

NACDS applauds California e-prescribing Law

ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) is applauding the enactment of an electronic prescribing bill (AB 2789) in California that will help to prevent opioid abuse. California Governor Jerry Brown signed the legislation yesterday. Effective January 1, 2022, the bill will require healthcare practitioners authorized to issue prescriptions to have

Senate passes NACDS-backed e-prescribing measure

Senate passes NACDS-backed e-prescribing measure

ARLINGTON, Va. –  The U.S. Senate just passed a package of measures focused on the opioid abuse epidemic, including the Every Prescription Conveyed Securely Act (S. 2460), which is backed by the National Association of Chain Drug Stores (NACDS). The legislation would require electronic prescribing for Schedule II through V controlled substances prescriptions covered under

1 2 3 17